cerebral dopamine neurotrophic factor (CDNF) Archives

Home Tags Cerebral dopamine neurotrophic factor (CDNF)

Renishaw’s 3D Printed drug delivery device successfully completes clinical drug trial for Parkinson disease

Kety S. - August 28, 2020

Early at the beginning of the year, Renishaw teamed up with researchers from Herantis Pharma plc, to help investigate cerebral dopamine neurotrophic factor (CDNF) as a...

About

Published by 3DA Solutions, 3D ADEPT Media is a trade press that tracks and analyses the latest trends in the additive manufacturing industry. As a source for high-quality, accurate, and timely additive manufacturing resources, we pride ourselves on delivering up-to-date information you can rely on through our online media and our print & interactive digital magazine 3D ADEPT Mag.

We love to think that this industry delivers “glocalized” manufacturing solutions to industries (in a nutshell, solutions that are both global and local). That is why we work with collaborators and partners across the world so that industries can easily identify the manufacturing path that best fits their needs. Learn more

CONTACT US : 3D ADEPT S.P.R.L (3DA)- VAT: BE0681.599.796
Rue Borrens 51 – 1050 Brussels
Email: contact@3dadept.com
Tel: +32(0)486745887

AMIS releases the Public Beta version 1 of its “AMIS Pro” software – designed for binder jetting

Ecogensus, the latest newcomer to join the AM industry, launches sustainable plastic substitutes

Provider of 3D printed maritime parts Pelagus 3D receives first ISO Certifications

AM 4 AM announces enhanced mechanical properties for its HiperAL aluminum alloy powder

Glidewell unveils new 3D-printed mandibular advancement device

3YOURMIND and RusselSmith to develop Additive Manufacturing hub for oil and gas in Nigeria

This is “Reusable”, a 3D printed reusable silicone cup

3D Systems receives FDA Clearance for 3D-Printed PEEK Cranial Implants

The quest to avoid or minimize support structures in Additive Manufacturing

Can Additive Manufacturing (AM) deliver “faulty” implications for its “green” credentials? (Part 3)

Key areas of focus in the application of ESG by AM companies (Part 2)

AM Companies must get started on their ESG journey. Here is how. (Part 1)

The use of AI and 3D Printing in construction

Beyond LPBF: Honeywell on finding the right opportunity with Additive Manufacturing

Thermwood’s Cut Layer Additive is an Additive Manufacturing process that does not 3D print. CEO Ken Susnjara explains why.

Greg Morris, the AMUG “Innovations Award Winner” on his journey, the adoption of AM across industries and the future of Zeda

Focus| Driving circular plastics economy in Additive Manufacturing

Ceramic 3D printing role in hydrogen production is more tangible. 3DCeram demonstrates it in the HyP3D project

Thermwood’s Cut Layer Additive is an Additive Manufacturing process that does not 3D print. CEO Ken Susnjara explains why.

Identifying defects in metal 3D printed parts can lead to up to 70% savings in production costs. Materialise explains how and why.

Download the 2024 March/April edition of 3D ADEPT Mag

Rapid.Tech 3D : New features that will mark this 20th anniversary

Get your free ticket for Hannover Messe 2024 and connect with companies beyond the AM industry

Additive Talks | How to ensure a pragmatic use of AM across the digital supply chain?

Tag: cerebral dopamine neurotrophic factor (CDNF)

Renishaw’s 3D Printed drug delivery device successfully completes clinical drug trial for Parkinson disease